NEW YORK – New research has uncovered non-coding mutations that can help drive the formation of glioblastoma (GBM) brain tumors through regulatory interactions that alter expression of new and known GBM-related genes, including non-coding variants that affect the promoter of the semaphorin-coding gene SEMA3C.